Julius Knowles - Director at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
KROS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Julius Knowles since 05 Jan 2025

Holdings reported by Julius Knowles for Keros Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 102,233 $1,814,635 $17.75 21 Nov 2025 Indirect
Common Stock 6,441 $112,717 $17.50 21 Nov 2025 Direct
Stock Option (right to buy) 10,500 04 Jun 2025 Direct Common Stock

Transactions reported by Julius Knowles for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.